Skip to content

Clinical trials

Immune System Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20102
20113
20122
20131
20151
20163
20172
20185
20191
20202
20215
20226
20239
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated12
Recruiting8
Active, not recruiting4
Enrolling by invitation2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Inmagene LLC4
Eli Lilly and Company3
Pfizer3
CRISPR Therapeutics AG2
Cogent Biosciences, Inc.2
GlaxoSmithKline2
McMaster University2
National Center for Research Resources (NCRR)2
Altair Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases56
Autoimmune Diseases22
Hypersensitivity11
Skin Diseases11
Dermatitis, Atopic9
Eczema9
Hypersensitivity, Immediate9
Dermatitis8
Connective Tissue Diseases7
Neoplasms7

Trials

Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.